Your search for dabigatran returned 33 results

No differences seen in fracture risk in head-to-head comparisons of direct oral anticoagulants

Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source

For patients initiating oral anticoagulant therapy, the incidence of hospitalization for upper gastrointestinal bleeding is highest and lowest with rivaroxaban and apixaban, respectively.

Compared with warfarin, apixaban was correlated with reduced risk of major bleeding and intracranial bleeding (adjusted hazard ratios, 0.66 and 0.4, respectively) and dabigatran was correlated with reduced risk of intracranial bleeding (adjusted hazard ratio, 0.45) among patients with atrial fibrillation.

The researchers found that the risk of developing an intraocular hemorrhage was reduced with dabigatran or rivaroxaban at 365 days (hazard ratio, 0.75; 95% confidence interval, 0.58 to 0.97; P=0.03) but not at 90 days (hazard ratio, 0.73; 95% confidence interval, 0.22 to 2.63; P=0.13).

Compared with warfarin, dabigatran and rivaroxaban linked to lower risk of adverse renal outcomes

Researchers performed a retrospective cohort study to compare incidence of stroke, bleeding, and myocardial infarction in patients with atrial fibrillation initiating dabigatran or warfarin (n=25,289 for each) from November 2010 to May 2014.

And antithrobotic medications linked to higher rate of hematuria-related events in older adults

Effective for dabigatran reversal among patients with uncontrolled bleeding, undergoing urgent surgery

Study of newer medications finds 16 percent receive too much or too little